Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
Clinical trial NCT03604783 · TERMINATED
Trial details
- NCT number
- NCT03604783
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-26
- Primary completion
- 2024-01-10
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.